Juan Sanchez | Vice President, Corporate Communications and Investor Relations |
Sharon Mates | Chairman and Chief Executive Officer |
Andrew Satlin | Executive Vice President and Chief Medical Officer |
Mark Neumann | Executive Vice President and Chief Commercial Officer |
Kimberly Vanover | Senior Vice President, Clinical Development and Translational Medicine |
Larry Hineline | Senior Vice President and Chief Financial Officer |
Michael Halstead | Executive Vice President and General Counsel |
Brian Abrahams | RBC Capital Markets |
Subbu Nambi | Cowen |
Sumant Kulkarni | Canaccord |
Jake Colby | BTIG |
Matt Kaplan | Ladenburg |
Good morning, ladies and gentlemen and welcome to the Intra-Cellular Therapies Fourth Quarter and Full Year Ended December 31, 2018 Financial Results Conference Call. At this time, all participants are in listen-only mode. Later there will be a question-and-answer session and instructions will follow at that time. [Operator Instructions] As a reminder, today’s conference call is being recorded. I would now like to turn the conference over to your host, Dr.